Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
5 citing papers in PubMed, 5 citations in OpenAlex.
Gérard GuédonDynAMic, Université de Lorraine, Institut national de recherche pour l'agriculture et l'environnement, Faculté des Sciences et Technologies, F-54000 CEDEX Nancy, France.ORCID 0000-0002-5289-3803
Julie LaoDynAMic, Université de Lorraine, Institut national de recherche pour l'agriculture et l'environnement, Faculté des Sciences et Technologies, F-54000 CEDEX Nancy, France.
Antonio CasabellaDepartment of Genetics and Microbiology, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.
José María MarimónBiodonostia, Infectious Diseases Area, Respiratory Infection and Antimicrobial Resistance Group, Osakidetza Basque Health Service, Donostialdea Integrated Health Organization, Microbiology Department, 20014 San Sebastián, Spain.ORCID 0000-0002-2787-7094
Emilia CercenadoResearch Network for Respiratory Diseases (CIBERES), Insituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.ORCID 0000-0002-5279-3773
Hélène ChiapelloMaIAGE, Université Paris-Saclay, Institut national de recherche pour l'agriculture et l'environnement, Domaine de Vilvert, F-78350 CEDEX Jouy-en-Josas, France.
Thomas LacroixMaIAGE, Université Paris-Saclay, Institut national de recherche pour l'agriculture et l'environnement, Domaine de Vilvert, F-78350 CEDEX Jouy-en-Josas, France.ORCID 0000-0002-6708-5809
María Ángeles DomínguezMicrobiology Department, Hospital Universitari Bellvitge, IDIBELL-UB, 08907 L'Hospitalet de Llobregat, Spain.
Nathalie Leblond-BourgetDynAMic, Université de Lorraine, Institut national de recherche pour l'agriculture et l'environnement, Faculté des Sciences et Technologies, F-54000 CEDEX Nancy, France.ORCID 0000-0001-5739-1370
Carmen ArdanuyMicrobiology Department, Hospital Universitari Bellvitge, IDIBELL-UB, 08907 L'Hospitalet de Llobregat, Spain.ORCID 0000-0003-0225-607X
Instituto de Salud Carlos III · ESUniversité Paris-Saclay · FRDynamique des Génomes et Adaptation Microbienne · FRBellvitge University Hospital · ESBiogipuzkoa Health Research Institute · ESUniversitat Autònoma de Barcelona · ES
Funding
Centro de Investigación Biomédica en Red CB21/13/0009Centro de Investigación Biomédica en Red de Enfermedades Respiratorias CB06/06/0037Instituto de Salud Carlos III PI21/01000
6 · The paper itself
Abstract
Tetracycline resistance in streptococci is mainly due to ribosomal protection mediated by the
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A New Integrative and Mobilizable Element Is a Major Contributor to Tetracycline Resistance in · full record | OpenQuestion